mTOR inhibition resulted in a steady increase in AKT T308 phosphorylation only in MDA-MB-468 cells but not in COR-L279 and LX95 cells, suggesting that a different mechanism is responsible for the drug synergy in SCLC (Supplemental Figure 11, A–E). This evidence concerns the gene AKT1 and small cell lung carcinoma.